High Inflammatory Factor Levels Increase Cardiovascular Complications in Diabetic Patients Undergoing Coronary Artery Bypass Grafting

Biomed Res Int. 2022 May 21:2022:7151414. doi: 10.1155/2022/7151414. eCollection 2022.

Abstract

Objective: To investigate the association between inflammation and clinical outcomes of coronary artery bypass grafting (CABG) in diabetic patients.

Methods: A total of 300 diabetic patients with coronary heart disease who underwent CABG were selected. Patients were divided into a group with cardiovascular events (32 in the MACCE group) and a group without cardiovascular events (268 in the non-MACCE group) according to whether cardiovascular events occurred within 30 days. The differences in clinical parameters; serum levels of TNF-α, IL-6, IL-18, IL-1β, and CRP; factors associated with the occurrence of MACCE; and risk factors affecting the midterm all-cause mortality of patients were compared between the two groups.

Results: The serum levels of TNF-α, IL-6, IL-18, and CRP in the MACCE group were significantly higher than those in the non-MACCE group (p < 0.05). Gender, smoking, hyperlipidemia, duration of diabetes, and levels of TNF-α, IL-6, IL-18, and CRP were closely related to the occurrence of MACCE. The Kaplan-Meier survival analysis evaluation results showed that the levels of IL-6 and CRP significantly affected the midterm all-cause mortality rate (p < 0.05). Multivariate Cox regression analysis showed that the advanced age, hypertension, hyperlipidemia, long duration of diabetes, elevated serum IL-6, and CRP levels could be used as risk factors for midterm all-cause mortality.

Conclusions: Inflammation levels in diabetic patients are associated with complications and midterm all-cause mortality in patients undergoing coronary artery bypass grafting.

Publication types

  • Retracted Publication

MeSH terms

  • Coronary Artery Bypass
  • Coronary Artery Disease* / complications
  • Coronary Artery Disease* / surgery
  • Diabetes Mellitus*
  • Humans
  • Inflammation* / complications
  • Interleukin-18
  • Interleukin-6
  • Tumor Necrosis Factor-alpha

Substances

  • Interleukin-18
  • Interleukin-6
  • Tumor Necrosis Factor-alpha